Incanthera Plc · AQUIS:INC
Incanthera — Proactive Investor Forum 2025
11 slides from Incanthera's conference presentation, Oct 9, 2025
Slide 1: Innovative Products for Dermatology and Oncology
Innovative Products for Dermatology and Proactive Investor Forum Oncology 9 October 2025
Slide 2: Disclaimer
Disclaimer • The information contained in these slides and any accompanying verbal presentation, any question and answer session and any document or material distributed at or in connection with the verbal presentation (together, the “Presentation”) have not been approved by an authorised person wit
Slide 3: Incanthera plc
Incanthera plc • Incanthera is a specialist company dedicated to innovative technologies in dermatology and oncology. • Established in 2010 as a spin out from the Institute of Cancer Therapeutics, University of Bradford. • Listed UK Aquis Stock Exchange (INC:AQSE), Feb 2020 • Incanthera’s recent foc
Slide 4: Skin+CELL
Skin+CELL Incanthera’s formulations are precisely finessed to deliver bioactive ingredients across the skin barrier, where it can reach the cellular structure, energising skin cells to effect change from the inside out. Our unique Skin+CELL range of products combine our unique formulations with bioa
Slide 5: Commercial Opportunity in a US$ Multi-Billion Market
Commercial Opportunity in a US$ Multi-Billion Market Skin+CELL is a revolutionary (biotech) skincare range utilising Incanthera’s unique cutting-edge delivery technology powered with a patented formulation delivered to the skin’s cells to activate optimal repair, restore and protective functions • T
Slide 6: Market Evolution Of Sales In Luxury Skincare/Cosmetics
Market Evolution Of Sales In Luxury Skincare/Cosmetics The beauty & cosmetic industry is evolving rapidly, driven by changing consumer expectations. Traditional marketing methods are becoming less effective, while influencer partnerships are proving to be a powerful tool for brands. • 98% Beauty Ind
Slide 7: Direct To Consumer (DTC) Agreement
Direct To Consumer (DTC) Agreement In June 2025, Incanthera announced an agreement with a global Direct to Consumer (DTC) Marketing Agency to launch Skin + CELL across a dedicated sales platform. • Launched on 11 August (www.skinandcell.com) the product range comprises: face, body and hand, face ser
Slide 8: Advantages of Direct to Consumer Strategy
Advantages of Direct to Consumer Strategy • Global Multi-billion US$ market • Incanthera controls (premium) retail selling price of the range • Increased revenues by selling direct to the customer • Greatly increased gross margins attributable direct to the Company • Immediate positive cash flow as
Slide 9: Looking forward……
Looking forward…… Dr Simon Ward, CEO on 30 September 2025: “There has been immediate positive feedback from users of our Skin+CELL products, extolling the beneficial impact on their skin tone and appearance and confirming that Skin+CELL will be an integral part of their skin and beauty regimen going
Slide 10: Delivering solutions of the future
Delivering solutions of the future 10
Slide 11: WWW.SKINANDCELL.COM
#SKINANDCELL WWW.SKINANDCELL.COM